Sanofi 20262027 Flu Vaccines

Awarded Limited / Sole Source Justification Posted

Solicitation number
19AQMM26F1490
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
19AQMM26F1490 Federal contract award
Place of performance
Swiftwater, Pennsylvania, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of State Office of Acquisition Management has awarded a sole-source delivery order to Sanofi Pasteur under the Department of Veterans Affairs Federal Supply Schedule contract (36F79722D0104) for High Dose Fluzone and Flublok Influenza vaccines for the 2026-2027 flu season, with an estimated order value of $68,964.00.

The vaccines are required to immunize embassy immunocompromised family members and provide disease prevention against three influenza strains. Sanofi Pasteur is the only manufacturer of high-dose Fluzone and Flublok egg-free influenza vaccines; these specific pediatric vaccines represent the first Quadrivalent Flu vaccines approved by the FDA. The sole-source justification rests on this monopoly status—no market research alternatives were identified. Cold chain storage must be maintained throughout delivery, with the Office of Logistics Management coordinating timely distribution to embassies and consulates prior to the start of the 2026-2027 flu season. The Contracting Officer determined the anticipated contract action represents best value and will evaluate the resultant price for reasonableness prior to award.

Notice text

Fluzone and Flublok Influenza Vaccines for the 2026-2027 Flu season. The vaccine is required to immunize embassy immunocompromised family members. 

Awarded contract 19AQMM26F1490 to unknown vendor for unknown amount on 2026-09-18.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity